Skip to content

GPX4 Expression After Kono-S vs Conventional Anastomosis

Oxidative Epithelial Injury After Ileocolic Resection a Retrospective Pilot Study Comparing Kono-S Versus Conventional Anastomotic Configurations Using Intestinal Epithelial GPX4 Expression.

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07772037
Enrollment
25
Registered
2026-08-19
Start date
2026-11-01
Completion date
2027-11-01
Last updated
2026-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chrohn's Disease

Keywords

anastomotic healing,, GPX4

Brief summary

Crohn's disease is a long-term condition that causes inflammation in the bowel. Many people with Crohn's will need surgery at some point to remove damaged sections of intestine. Although surgery can improve symptoms, the disease often comes back near the join (anastomosis) where the bowel has been reconnected. Surgeons use different techniques to reconnect the bowel. One newer approach, called the Kono-S anastomosis, is designed to reduce the risk of Crohn's disease returning. Early results are promising, but it is still not fully understood why it may work better than traditional methods. This project aims to explore how the bowel heals after surgery by looking at oxidative stress, a type of tissue damage caused by an imbalance of harmful molecules in the body. The investigators will focus on a protective protein called glutathione peroxidase-4 (GPX4), an anti-oxidative enzyme that reduces oxidized phospholipids in biomembranes. By analysing tissue samples taken before and after surgery, the investigators will compare patients who had the Kono-S technique with those who had standard surgical joins. The investigators want to see whether differences in healing at a microscopic level could explain why some patients do better than others. The findings from this study could: * Improve understanding of why Crohn's disease comes back after surgery. * Help surgeons choose the best technique for each patient. * Support the development of new treatments aimed at improving healing. Ultimately, this research aims to reduce the risk of disease recurrence and improve long-term outcomes for people living with Crohn's disease.

Detailed description

Postoperative recurrence of Crohn's disease frequently occurs at or near the ileocolic anastomosis.1 Increasing evidence suggests that oxidative stress plays a central role in anastomotic healing, fibrosis and mucosal recurrence. Surgical injury triggers neutrophil recruitment and reactive oxygen species (ROS) production, which can initiate lipid peroxidation within intestinal epithelial membranes.3 Lipid peroxidation products such as malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE) activate inflammatory and fibrotic signalling pathways including mitogen-activated protein kinase (MAPK), nuclear factor-κB (NF-κB) and transforming growth factor- β (TGF-β).2,4 GPX4 is a key antioxidant enzyme that detoxifies lipid peroxides and prevents ferroptosis, a regulated form of oxidative cell death.5 Reduced GPX4 activity has been described in inflammatory bowel disease and may contribute to epithelial injury and disease progression.5 Recent results have demonstrated that a reduced GPX4 expression at time of surgery predicts disease recurrence after ileocolonic resection independent of established clinical risk factors (e.g., smoking, penetrating disease, sex and age). Despite the recognised importance of oxidative stress in intestinal inflammation, its role at the surgical anastomosis in Crohn's disease has not been directly studied. The Kono-S anastomosis is a functional end-to-end, antimesenteric configuration designed to reduce luminal distortion and faecal stasis while excluding mesenteric inflammatory influence. Early studies suggested reduced endoscopic recurrence compared with conventional anastomoses, although long-term clinical results remain mixed.6 The biological mechanisms underlying any benefit remain poorly understood. The investigators hypothesise that the Kono-S anastomotic configuration may reduce local oxidative stress at the anastomotic site by limiting reactive oxygen species exposure and subsequent lipid peroxidation, as reflected by lower levels of markers such as malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE) compared with conventional techniques. This more favourable redox environment may support preservation of epithelial antioxidant defence mechanisms, including maintenance of glutathione peroxidase-4 (GPX4) expression and activity, thereby reducing susceptibility of intestinal epithelial cells to ferroptosis. In turn, reduced lipid peroxidation may attenuate activation of key pro-inflammatory and pro-fibrotic signalling pathways, including MAPK, NF-κB and TGF-β, with potential downstream effects on mucosal inflammation and fibrotic remodelling.4 Overall, these mechanisms may contribute to improved anastomotic healing and a lower risk of early endoscopic recurrence.

Interventions

None listed

Sponsors

East Kent Hospitals University NHS Foundation Trust
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

• Adults (≥18 years) with confirmed Crohn's disease who underwent ileocolic or small bowel resection with a primary anastomosis. * Documented anastomotic configuration (Kono-S or conventional). * Availability of archived pathology material from the resection specimen containing the anastomotic site. * At least one additional tissue timepoint available: preoperative endoscopic biopsy or follow up endoscopic biopsy within 24 months. * Available postoperative endoscopic follow up data (Rutgeerts score) where applicable.

Exclusion criteria

* • Indeterminate colitis or non-Crohn's pathology on histology. * Lack of retrievable tissue or poor tissue quality (e.g., extensive necrosis or autolysis) precluding IHC. * Unclear anastomotic type. * Absence of epithelial component in the available tissue (e.g., only serosa or fibrofatty tissue). * Major confounders that could affect GPX4 expression, such as severe ischaemia, uncontrolled sepsis, or immediate reoperation at the anastomotic site. * Patients with permanent stomas and no anastomotic follow up where interpretation would be ambiguous.

Design outcomes

Primary

MeasureTime frameDescription
• Difference in epithelial GPX4 expression score between Kono-S and conventional groups at the anastomotic site 6-12 months after IC resection.6-12 months after IC resection.• Difference in epithelial GPX4 expression score between Kono-S and conventional groups at the anastomotic site 6-12 months after IC resection. The scale consists of n- not detected ( high reoccurrence risk) l- low level (high reoccurrence risk) m-medium level (low reoccurrence risk) h-high level (low reoccurrence risk)

Secondary

MeasureTime frameDescription
• Association between GPX4 expression and Rutgeerts score / endoscopic recurrence6-12 months after IC resection• Association between GPX4 expression and Rutgeerts score / endoscopic recurrence. Rutgeerts score i0- no lesions (best outcome) i1- not more than 5 lesions i2 \>5 lesions i3 \>5 lesions i4 \>5 lesions (worst outcome) is the accepted score. Is there any correlation with the levels of GPX4 (n/l/m,h) in the participants?
• Within patient change in GPX4 across pre-operative, operative and follow up tissues6-12 months after IC resection• Within patient change in GPX4 across pre-operative, operative and follow up tissues
• Association between GPX4 and histological inflammation, fibrosis/stricture phenotype, or restenosis.6-12 months after IC resection• Association between GPX4 and histological inflammation, fibrosis/stricture phenotype, or restenosis.

Countries

United Kingdom

Contacts

CONTACTGiuseppe Preziosi, MD
g.preziosi@nhs.net+ 44 1843 225544.
STUDY_CHAIRCaroline Cowley

East Kent Hospitals University Foundation Trust

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 20, 2026